2026 · 1st Quarter (Jan 1 - Mar 31)

THE UNITED STATES PHARMACOPEIAL CONVENTION

Filed by THE UNITED STATES PHARMACOPEIAL CONVENTION.

Open official filing

Source-reported fields

Filing overview

Type: 1st Quarter - Report
Posted: Apr 21, 2026
Income: Not reported
Expenses: $110,000.00
Registrant: THE UNITED STATES PHARMACOPEIAL CONVENTION
Client: THE UNITED STATES PHARMACOPEIAL CONVENTION
Filing UUID: f5d6311c-a068-40fd-9f03-d203b4e9a658
Termination date: Not reported

Expense method: B

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

S. 1784 - Mapping America's Pharmaceutical Supply (MAPS) Act; H.R. 4191: Provisions regarding supply chain security and resilience and drug shortages. S. 3788 - Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings Act (CLEAR LABELS) Act: Provisions regarding drug labeling.

Literal federal measure citations: S. 1784, H.R. 4191, S. 3788

BUD · Budget/Appropriations

Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027: Provisions related to Administration for Strategic Preparedness and Response (ASPR) mapping. FY 2027 Commerce, Justice, Science, and Related Agencies Appropriations: Provisions related to 3D-printing. FY 2027 State-Foreign Operations Appropriations: Provisions related to pharmaceutical supply chain resilience.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.